Top

CAR-T Cell Therapy in Autoimmune Diseases as Concomitant or Main Indication: a 2-step Joint Study on behalf of EBMT ADWP and CTIWP

… CAR-T Cell Therapy in Autoimmune Diseases Please complete the … policy for the management of AD patients treated with CAR-T. Contact information Centre’s characteristics … CAR-T Cell Therapy in Autoimmune Diseases as Concomitant or Main …

Real-world CAR-T practice patterns in patients with mantle cell lymphoma: an international survey on behalf of the EBMT lymphoma working party

… Real-world CAR-T practice patterns in patients with mantle cell lymphoma: an …

51st EBMT Annual Meeting Session: EBMT - T2EVOLVE roundtable | Implementing Patient-Friendly Informed Consent Forms in CAR-T Clinical Studies: Insights and Solutions

… | Implementing Patient-Friendly Informed Consent Forms in CAR-T Clinical Studies: Insights and Solutions …

CAR-T cell manufacturing failures and out-of-specification products in the real-world setting: A survey from the EBMT cellular therapy and immunobiology working party

… CAR-T cell manufacturing failures and out-of-specification …

The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by the Cellular Therapy and Immunobiology Working Party of the EBMT

… The landscape of immune monitoring in CAR-T cell therapy: A comprehensive review and survey study by …

Open Call for the GoCART Observership Programme

… Are you an emerging CAR-T centre looking to learn from an experienced team? Or are you an established CAR-T centre interested in mentoring the next generation of …

Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT

… Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on …

Set-up of the Data Collection Initiative to support the PAS studies

… PAS studies for currently available as well as future CAR-T therapies. Until this ICF is approved by the applicable … The contracts for the Data Collection Initiative on CAR-T are split in two parts. The Data Collection Master … Report data on all patients treated with CAR-T therapy within six weeks of the patient's treatment or …

EBMT 2025 Annual Meeting - Jian-Jian Luan Award to Magdalena Corona de Lapuerta

… OF CD19 IN LARGE B-CELL LYMPHOMA PATIENTS RECEIVING CAR-T THERAPY Oral Presenter: Magdalena Corona (New York, United … of CD19 in Large B-Cell Lymphoma Patients Receiving CAR-T Therapy’, was recently awarded the Jian-Jian Award for …

Scientific report 2021 of the Cellular Therapy and Immunobiology Working Party (CTIWP)

… Effector Cells (IECs) based therapies, of which autologous CAR-T cells remain the most publicized. Registrations of CAR-T Cells treated patients continues and now nears 2,000 …